Clinical Trial Update: A Study of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients [Phase 1]

View source ↗

Summary

Phase 1 study evaluating intravenous and oral isavuconazonium sulfate in pediatric patients with hematologic malignancies has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies

Drugs mentioned

• Isavuconazonium sulfate (isavuconazonium sulfate)

Snippet

Sponsor: Astellas Pharma Global Development, Inc. | Conditions: Hematological Malignancy | Phase 1 | Status: COMPLETED